Single-cell capture of on-ART SIV transcription reveals TGF-β–mediated metabolic control of viral latency
Authors:
- Romaila Abd-El-RaoufRARomaila Abd-El-Raouf
- Jakob Harrison-GleasonJHJakob Harrison-Gleason
- Jinhee KimJKJinhee Kim
- Ching Man WaiCWChing Man Wai
- Kayla L. YerliogluKYKayla L. Yerlioglu
- Catarina Ananias-SaezCACatarina Ananias-Saez
- Alec KsiazekAKAlec Ksiazek
- Jeffrey T. PoomkudyJPJeffrey T. Poomkudy
- Mariluz AraíngaMAMariluz Araínga
- Deepanwita BoseDBDeepanwita Bose
- Claudia CicalaCCClaudia Cicala
- James ArthosJAJames Arthos
Open Access
- 23 February 2026
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 11 (4)
Abstract
We previously demonstrated that blocking TGF-β with galunisertib, a safe, orally available small drug, reactivated latent SIV in vivo by shifting T cells toward a transitional effector phenotype. Here, we investigated the mechanisms underlying this effect using single-cell RNA sequencing, metabolic profiling, and high-dimensional spectral flow cytometry of samples from SIV-infected, antiretroviral therapy–treated (ART-treated) macaques before and after galunisertib. To characterize virus-transcribing, infected cells during ART, we developed a novel, sensitive SIV Transcripts Capture Assay (SCAP) that detected 127 SIV-expressing cells within lymph node single-cell transcriptome libraries. Galunisertib drove broad metabolic reprogramming in CD4 + T cells, with transcriptional upregulation of inflammatory and mitochondrial biosynthesis pathways, confirmed by Seahorse profiling. Metabolomics revealed increased energy metabolites and amino acids and enhanced metabolic flux without proliferation. SIV transcript–positive cells before galunisertib were metabolically quiescent compared with cells without detectable viral transcripts. After galunisertib, virus-expressing cells showed a dramatic metabolic activation, with upregulation of glycolysis, fatty acid metabolism, and TNF-α signaling. High-dimensional flow cytometry demonstrated effects beyond CD4 + T cells, including fewer tissue-resident memory T cells, but more inflammatory macrophages. In conclusion, SCAP represents a specific tool for characterizing rare SIV-infected cells transcribing virus during ART, and it reveals TGF-β as a key mediator of viral latency in vivo through metabolic suppression.Keywords
Funding Information
- National Institutes of Health (R01 AI176599,R24 OD010947,P30 CA060553)
This publication has 85 references indexed in Scilit:
- Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding PlacesCurrent HIV/AIDS Reports, 2025
- TGF-β Signaling Supports HIV Latency in a Memory CD4+ T Cell Based In Vitro Model2022
- MiR-141-3p and miR-200a-3p are involved in Th17 cell differentiation by negatively regulating RARB expressionHuman Cell, 2021
- T‐bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1European Journal of Immunology, 2018
- Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infectionFEBS Letters, 2017
- Calcium–NFAT transcriptional signalling in T cell activation and T cell exhaustionCell Calcium, 2017
- Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with PrognosisCell, 2015
- FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry dataCytometry Part A, 2015
- Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory networkBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Mammalian polyamine metabolism and functionIUBMB Life, 2009